Effects of spinasterol and sitosterol on plasma and liver cholesterol levels and biliary and fecal sterol and bile acid excretions in mice.
Effects of spinasterol and sitosterol on plasma and liver cholesterol levels and biliary and fecal sterol and bile acid excretions were examined with male mice. Both phytosterols were added to the diet at a 1% concentration and fed to mice for 15 days. Spinasterol increased the fecal cholesterol excretion and decreased the plasma and liver cholesterol levels, the bile acid pool size and the fecal bile acid excretion, especially those derived from chenodeoxycholic acid. Fecal coprostanol excretion remained unchanged. These changes were similar to those produced by sitosterol. These data led to the conclusions 1) that spinasterol, as well as sitosterol, inhibits cholesterol absorption, resulting in decreases of the plasma and liver cholesterol levels and 2) that when cholesterol absorption is inhibited, the synthesis of bile acids, especially that of chenodeoxycholic acid, decreases, suggesting that the dietary cholesterol is preferentially metabolized to chenodeoxycholic acid in mice.
D000818:Animals; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D010743:Phospholipids / Q000097:blood; D010840:Phytosterols / Q000494:pharmacology*; D012855:Sitosterols / Q000494:pharmacology*; D013261:Sterols / Q000378:metabolism*; D013265:Stigmasterol / Q000031:analogs & derivatives / Q000494:pharmacology*
D001647:Bile Acids and Salts; D010743:Phospholipids; D010840:Phytosterols; D012855:Sitosterols; D013261:Sterols; C031312:spinasterol; C025473:gamma-sitosterol; D002784:Cholesterol; D013265:Stigmasterol